Description
Fragment 176-191 SPECIFICATIONS
AKA: Frag 176-191
Molecular Formula: C78H125N23O23S2
Molecular Weight: 1817.1 g/mol
Sequence: Tyr-Leu-Arg-Ile-Val-Gin-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
CAS Number: 66004-57-7
Reconstitution: Required
Mod GRF 1-29 SPECIFICATIONS
AKA: Modified GRF (1-29)
Molecular Formula: C212H350N56O78S
Molecular Weight: 3367.89 g/mol
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
PubChem: CID 56841945
CAS Number: 863288-34-0
Reconstitution: Required
Ipamorelin SPECIFICATIONS
Molecular Formula: C38H49N9O5
Molecular Weight: 711.85 g/mol
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
PubChem: CID 20754357
CAS Number: 170851-70-4
Reconstitution: Required
Potential of Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Peptides Blend
Studies have proven that highest output of growth hormone (GH) from the anterior pituitary gland can be attained through a combination of growth hormone-releasing hormone (GHRH) analog and agonist of growth hormone secretagogue receptor (GHSR). The combination of ipamorelin with modified GRF is one of the various combinations which help to achieve the above objective. Interestingly, more specific results can be achieved beyond the increase in GH synthesis through the refinement of the choice of GHRH analog and GHSR agonist used.
Modified GRF, also an effective GHRH analog has effects beyond the improvement of GH release. It has proven to benefit intestinal inflammation, wound healing and cardiac function in animal models. The introduction of ipamorelin along with modified GRF triggers the highest expression of GH. Ipamorelin further improves bone growth and the stabilization of the cellular matrix. The above physiological outcomes are in addition to the improvement of bone development caused directly through increased GH release.
Research has shown that fragment 176-191, a synthetic GHRH agonist is a strong catalyst for catabolism of adipocytes. Hence it is now possible to bring about targeted lipolysis by including fragment 176-191 with ipamorelin and Mod GRF 1-29. It is way more effective than most of the GHRH agonists in burning of fat and hence is popularly called as “lipolytic fragment.” Thus inclusion of fragment 176-191 improves fat metabolism in the premise of increased GH release and modifies physiological metabolism in favor of lean body mass. Only buy Fragment 176-191 & Mod GRF 1-29 & Ipamorelin blend if you are a licensed researcher.
